Different dosage regimens of Eptinezumab for the treatment of migraine: a meta-analysis from randomized controlled trials

BACKGROUND: Migraine is one of the most common neurological diseases around the world and calcitonin gene-related peptide (CGRP) plays an important role in its pathophysiology. Therefore, in the present study, we evaluated the efficacy of monoclonal antibodies blocking the CGRP ligand or receptor in...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Zeya, Xue, Tao, Chen, Shujun, Wu, Xin, Yang, Xingyu, Liu, Guangjie, Gao, Shan, Chen, Zhouqing, Wang, Zhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937260/
https://www.ncbi.nlm.nih.gov/pubmed/33676408
http://dx.doi.org/10.1186/s10194-021-01220-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937260/
https://www.ncbi.nlm.nih.gov/pubmed/33676408
http://dx.doi.org/10.1186/s10194-021-01220-y

Ejemplares similares